A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis

Study Identifier
191622-046
CT.gov Identifier
NCT00168402
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Other
    • Study Drug
  • Botulinum Toxin Type A
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18 - 75 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Marked axillary hyperhidrosis
    Exclusion Criteria:
    * Previous use of botulinum toxin for hyperhidrosis

    Protocol Summary

    This is a three-year study in subjects with axillary hyperhidrosis involving injection of Botulinum Toxin Type A into the axilla to reduce sweating.

    Study Locations

    No locations found.